Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Centre, Prospective, Observational Study of Patient Reported Outcomes in Patients Diagnosed With Cervical Dystonia and Treated With OnabotulinumtoxinA for Injection (BOTOX®) (POSTURe)

NCT01655862 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT01655862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01655862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Centre, Prospective, Observational Study of Patient Reported Outcomes in Patients Diagnosed With Cervical Dystonia and Treated With OnabotulinumtoxinA for Injection (BOTOX®) (POSTURe)
Lead sponsor
Allergan
Phase
Observational
Overall status
Completed
Start date
July 31, 2012
Completion date
February 28, 2017
Enrollment
62 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

torticollis